多指标联合评估对慢性阻塞性肺疾病病情严重程度的预测价值
Predictive Value of Multi-Index Combined Assessment for the Severity of Chronic Obstructive Pulmonary Disease
DOI: 10.12677/acm.2025.1582271, PDF,   
作者: 王 磊, 刘 伟:日照市人民医院呼吸与危重症医学科,山东 日照;康福来:重庆市黔江区中医院肺病科,重庆;朱洪柱:日照市人民医院城西分院结核科,山东 日照;陈成成*:日照市人民医院放射科,山东 日照
关键词: 慢性阻塞性肺疾病病情严重程度多模态评估炎症标志物预测模型Chronic Obstructive Pulmonary Disease Disease Severity Multimodal Assessment Inflammatory Markers Predictive Model
摘要: 目的:探讨多指标联合评估模型对慢性阻塞性肺疾病(COPD)病情严重程度分级的预测价值。方法:采用横断面研究设计,纳入80例COPD患者(按GOLD标准分级)和80例健康对照者。评估指标包括肺功能(FEV1%预计值、FVC、FEV1/FVC)、炎症指标(hs-CRP、中性粒细胞/淋巴细胞比值)、凝血功能(D-二聚体、纤维蛋白原)及代谢指标(同型半胱氨酸)。采用方差分析、LASSO回归和机器学习算法筛选关键预测变量并构建综合评估模型。结果:研究发现,随着COPD病情加重,全身炎症标志物(hs-CRP: GOLD I vs. IV, 30.82 vs. 41.56 mg/L, P < 0.05)和凝血功能异常(D-二聚体:0.97 vs. 0.71 μg/mL)呈阶梯式上升。由FEV1%、hs-CRP和D-二聚体组成的联合预测模型表现出最优的鉴别能力(AUC = 0.923, 95%CI: 0.891~0.955),显著优于单项肺功能指标(FEV1% AUC = 0.83)。关键发现包括:D-二聚体与FEV1/FVC比值呈强负相关(r = −0.78, P < 0.001);hs-CRP联合D-二聚体对重度患者的识别灵敏度达92%;同型半胱氨酸水平在中–重度病例间存在显著差异(13.6 vs. 7.6 μmol/L, P < 0.001)。结论:多指标联合评估模型整合了肺功能、炎症和凝血功能参数,相较于传统的单一指标评估方法,能更精准地预测COPD病情严重程度,具有更高的临床应用价值。
Abstract: Objective: To explore the predictive value of a multi-index combined assessment model for disease severity classification in chronic obstructive pulmonary disease (COPD). Methods: A cross-sectional study was conducted on 80 COPD patients (stratified by GOLD criteria) and 80 healthy controls. Comprehensive assessments included pulmonary function (FEV1% predicted value, FVC, FEV1/FVC ratio), inflammatory markers (hs-CRP, neutrophil-to-lymphocyte ratio), coagulation parameters (D-dimer, fibrinogen), and metabolic indicators (homocysteine). ANOVA, LASSO regression, and machine learning modeling were performed to identify key predictive variables and construct an integrated evaluation model. Results: The study demonstrated significant stepwise increases in systemic inflammation markers (hs-CRP: GOLD I vs. IV, 30.82 vs. 55.56 vs. 41.56 mg/L, P < 0.05) and coagulation dysfunction (D-dimer: 0.97 vs. 0.71 μg/mL) with disease progression. The combined predictive model comprising FEV1%, hs-CRP, and D-dimer demonstrated optimal discriminatory ability (AUC = 0.923, 95%CI: 0.891~0.955) compared to single pulmonary function indicator assessments (FEV1% AUC = 0.83). Key findings included: D-dimer was strongly negatively correlated with the FEV1/FVC ratio (r = −0.78, P < 0.001); The combination of hs-CRP and D-dimer achieved a sensitivity of 92% for identifying severe cases; Homocysteine levels showed significant differences between moderate and severe cases (13.6 vs. 7.6 μmol/L, P < 0.001). Conclusion: The multi-index combined assessment model synergistically integrates pulmonary function, inflammatory, and coagulation function parameters, and it can more accurately predict the severity of COPD and has higher clinical application value compared to conventional single-index assessment methods.
文章引用:王磊, 康福来, 朱洪柱, 刘伟, 陈成成. 多指标联合评估对慢性阻塞性肺疾病病情严重程度的预测价值[J]. 临床医学进展, 2025, 15(8): 590-598. https://doi.org/10.12677/acm.2025.1582271

参考文献

[1] Rabe, K.F., Hurd, S., Anzueto, A., Barnes, P.J., Buist, S.A., Calverley, P., et al. (2007) Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary. American Journal of Respiratory and Critical Care Medicine, 176, 532-555. [Google Scholar] [CrossRef] [PubMed]
[2] Gautam, S.S. and O’Toole, R.F. (2016) Convergence in the Epidemiology and Pathogenesis of COPD and Pneumonia. COPD: Journal of Chronic Obstructive Pulmonary Disease, 13, 790-798. [Google Scholar] [CrossRef] [PubMed]
[3] 刘俊彦, 李玉英, 吕学军, 等. COPD患者急性加重期呼吸道分泌性白细胞蛋白酶抑制剂含量调节机制研究进展[J]. 山东医药, 2016, 56(11): 99-101.
[4] Li, C., Lian, X., He, J., Gao, X., Liu, X., Bao, C., et al. (2024) Association of Computed Tomography-Derived Pectoralis Muscle Area and Density with Disease Severity and Respiratory Symptoms in Patients with Chronic Obstructive Pulmonary Disease: A Case-Control Study. Respiratory Medicine, 233, Article ID: 107783. [Google Scholar] [CrossRef] [PubMed]
[5] Corhay, J.L., Bonhomme, O., Heinen, V., Moermans, C. and Louis, R. (2022) Chronic Obstructive Pulmonary Disease. A Chronic Inflammatory Disease. Revue Médicale de Liège, 77, 295-301.
[6] Zatloukal, J., Brat, K., Neumannova, K., Volakova, E., Hejduk, K., Kocova, E., et al. (2020) Chronic Obstructive Pulmonary Disease—Diagnosis and Management of Stable Disease; a Personalized Approach to Care, Using the Treatable Traits Concept Based on Clinical Phenotypes. Position Paper of the Czech Pneumological and Phthisiological Society. Biomedical Papers, 164, 325-356. [Google Scholar] [CrossRef] [PubMed]
[7] Heo, J., Moon, D.H., Hong, Y., Bak, S.H., Kim, J., Park, J.H., et al. (2021) Word Embedding Reveals Cyfra 21-1 as a Biomarker for Chronic Obstructive Pulmonary Disease. Journal of Korean Medical Science, 36, e224. [Google Scholar] [CrossRef] [PubMed]
[8] Milacić, N., Milacić, B., Milojković, M., et al. (2016) Correlation of C-Reactive Protein and COPD Severity. Acta Clinica Croatica, 55, 41-48. [Google Scholar] [CrossRef
[9] Silva, L.L.S.d., Barbosa, J.A.S., João, J.M.L.G., Fukuzaki, S., Camargo, L.d.N., dos Santos, T.M., et al. (2023) Effects of a Peptide Derived from the Primary Sequence of a Kallikrein Inhibitor Isolated from Bauhinia bauhinioides (Pep-BbKI) in an Asthma-COPD Overlap (ACO) Model. International Journal of Molecular Sciences, 24, Article No. 11261. [Google Scholar] [CrossRef] [PubMed]
[10] Chen, L., Xu, W., Chen, J., Zhang, H., Huang, X., Ma, L., et al. (2023) Evaluating the Clinical Role of Fibrinogen, D-Dimer, Mean Platelet Volume in Patients with Acute Exacerbation of COPD. Heart & Lung, 57, 54-58. [Google Scholar] [CrossRef] [PubMed]
[11] 周蓉. C反应蛋白和血白细胞计数及肺功能检测对慢性阻塞性肺疾病的评估价值[J]. 临床合理用药杂志, 2019, 12(9): 135-137.
[12] 王志峰, 符之月, 王春刚, 等. 慢性阻塞性肺疾病患者hs-CRP水平变化及其与肺功能、血气分析的相关性研究[J]. 安徽医药, 2014, 18(11): 2152-2154.
[13] 杨秀娜, 杨梅, 刘新会, 等. 慢性阻塞性肺疾病患者血清IL-13、TGF-α浓度变化及其肺功能相关性研究[J]. 实用预防医学, 2017, 24(1): 92-94.
[14] 王淑锦, 姚婷婷, 李璐, 等. 血清sCD163水平与慢性阻塞性肺疾病急性加重期患者炎症因子及气道重塑的关系[J]. 中国急救复苏与灾害医学杂志, 2024, 19(8): 1034-1037+1054.
[15] 周盈, 曹磊, 平芬. 慢性阻塞性肺疾病相关炎性细胞因子的研究进展[J]. 临床荟萃, 2020, 35(3): 273-276.
[16] 范春红, 李时悦, 李明, 等. IFN-γ、IL-32、IL-1β在慢性阻塞性肺疾病中的临床意义[J]. 中外医疗, 2011, 30(19): 21-23.
[17] 张镜锋, 谢剑斌, 梁淦桐. 老年COPD患者血清hs-CRP、IL-1β、TNF-α水平的变化及临床意义[J]. 海南医学, 2018, 29(10): 1401-1403.
[18] 蒋凌志, 许丹媛, 杨志雄. 老年COPD患者血清PCT、hs-CRP的表达与肺功能指标、生活质量的相关性[J]. 中国老年学杂志, 2018, 38(7): 1623-1625.
[19] Agustí, A. and Faner, R. (2012) Systemic Inflammation and Comorbidities in Chronic Obstructive Pulmonary Disease. Proceedings of the American Thoracic Society, 9, 43-46. [Google Scholar] [CrossRef] [PubMed]
[20] Xu, Z., Li, F., Xin, Y., Wang, Y. and Wang, Y. (2024) Prognostic Risk Prediction Model for Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD): A Systematic Review and Meta-Analysis. Respiratory Research, 25, Article No. 410. [Google Scholar] [CrossRef] [PubMed]
[21] 赵修斌, 曾亚, 肖云武. 慢性阻塞性肺疾病患者血中炎性因子变化与呼吸功能的相关性研究[J]. 实用预防医学, 2007(4): 1052-1054.